Focus Partners Advisor Solutions’s MediciNova MNOV Stock Holding History

Focus Partners Advisor Solutions’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.2K	Buy	+10,000	New	+$13.7K	﹤0.01%	1240
2026 Q1	–	Sell	-10,000	Closed	-$13.1K	–	1316
2025 Q4	$13.1K	Buy	+10,000	New	+$13.8K	﹤0.01%	1086
2024 Q4	–	Sell	-10,000	Closed	-$21K	–	837
2024 Q3	$21K	Buy	+10,000	New	+$14.8K	﹤0.01%	751
2022 Q4	–	Sell	-10,000	Closed	-$22K	–	391
2022 Q3	$22K	Buy	+10,000	New	+$23.1K	﹤0.01%	402
2022 Q1	–	Sell	-10,000	Closed	-$27K	–	345
2021 Q4	$27K	Buy	+10,000	New	+$33.4K	0.01%	144

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Focus Partners Advisor Solutions's MNOV Position: Q2 2026 in Review

Focus Partners Advisor Solutions opened a new position in MediciNova (MNOV) in Q2 2026: 10,000 shares worth $13.2K. The stake represents ﹤0.01% of the portfolio and ranks #1240 among its holdings. This is a return to the name: Focus Partners Advisor Solutions previously reported a position in MNOV as recently as Q4 2025.

Focus Partners Advisor Solutions first reported a position in MNOV in Q4 2021 and has held it in 5 quarters since. The position peaked at $27K in Q4 2021. 28 funds tracked by Wall St. Rank hold MNOV as of Q2 2026.

Focus Partners Advisor Solutions held 10,000 shares of MediciNova worth $13.2K as of Q2 2026.
MediciNova was a new Focus Partners Advisor Solutions position in Q2 2026.
MediciNova made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #1240 holding.
Focus Partners Advisor Solutions first reported a position in MediciNova in Q4 2021 and has held it in 5 quarters since.
Focus Partners Advisor Solutions's MediciNova position peaked at $27K in Q4 2021.
28 funds tracked by Wall St. Rank held MediciNova as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.